Harvard/Partners Center for Genetics and Genomics Will Use Affy Arrays in Atherosclerosis Genotyping Study

NEW YORK, Feb. 16 (GenomeWeb News) - The Center for Genetics and Genomics of Harvard Medical School and Partners HealthCare will use Affymetrix's GeneChip Human Mapping microarrays in a genotyping study of atherosclerosis, the two institutions said today.

HPCGG will obtain the arrays by the end of June under an early access program. In the study, which is funded by the Reynolds Foundation, researchers will genotype more than 1,200 patient samples from the Women's Health Study, an ongoing NIH study of cardiovascular disease in which 38,000 women participate.

The Human Mapping array is capable of scanning up to 500,000 SNPs, according to Affymetrix.